the story behind targeting flt3 in aml and the next generation of inhibitors
Published 6 years ago • 60 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
2:40
an overview of the safety profile of flt3 inhibitors in aml
-
3:27
novel flt3 inhibitors for aml
-
0:53
recent advances in the targeting of flt3 in aml
-
2:15
targeting flt3 in aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
27:21
fbtb 2023: ellen lupton – storytelling and visual design
-
15:26
the power of labels to change your story | elaine mendoza | tedxusfsm
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
2:17
updates on the flt3 inhibitor ff-10101 for the treatment of r/r aml
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:40
sf3b1 as therapeutic target in flt3/itd positive aml
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
1:52
the management of r/r flt3-mutated aml
-
20:29
role of flt3 inhibitors and other novel agents in aml
-
1:04
flt3 inhibitors – an ideal strategy for treating flt3-mutated aml
-
1:50
mechanisms of gilteritinib resistance in flt3-mutated aml
-
2:15
novel agents in trials for aml: quizartinib and gilteritinib